Piritrexim
Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
325.37
Molecular Formula
C17H19N5O2
Notes
Research use only, not for human use.
Receptor
DHFR
CAS Number
72732-56-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
7-15129 1 Kit
Mouse Embryo FibrOut™1: Fibroblast Inhibitory System (for 500 mL medium)
Ask
View Details 